Proton magnetic resonance spectroscopy (1H-MRS) in rheumatic autoimmune diseases: A systematic review.

Renan Bazuco FrittoliDanilo Rodrigues PereiraLeticia RittnerSimone Appenzeller

Published in: Lupus (2020)

The presence of neurometabolite abnormalities in patients without ouvert CNS manifestations, suggests that systemic inflammation, atherosclerosis or abnormal vascular reactivity may be associated with subclinical CNS manifestations. MRS may be a usefull non-invasive method for screening patients with risk for CNS manifestations.

Keyphrases

end stage renal disease
blood brain barrier
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
peritoneal dialysis
prognostic factors
type diabetes